Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
Authors
Keywords
Chemotherapy, Docetaxel, Cisplatin, 5-fluorouracil, Esophageal carcinoma
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 77, Issue 6, Pages 1143-1152
Publisher
Springer Nature
Online
2016-02-20
DOI
10.1007/s00280-016-2985-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcomes of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil Followed by Esophagectomy in Patients with Resectable Node-Positive Esophageal Cancer
- (2014) Masayuki Watanabe et al. ANNALS OF SURGICAL ONCOLOGY
- Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807)
- (2014) Shuichi Hironaka et al. CANCER SCIENCE
- Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma
- (2013) Hiroki Hara et al. CANCER SCIENCE
- Multimodality approach for locally advanced esophageal cancer
- (2012) Khaldoun Almhanna WORLD JOURNAL OF GASTROENTEROLOGY
- Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial
- (2011) L. E. Ferri et al. ANNALS OF ONCOLOGY
- A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
- (2011) Nobutoshi Ando et al. ANNALS OF SURGICAL ONCOLOGY
- Multicenter Phase I/II Study of Docetaxel, Cisplatin and Fluorouracil Combination Chemotherapy in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Esophagus
- (2011) Makoto Yamasaki et al. ONCOLOGY
- Progress in multidisciplinary treatment for esophageal cancer in Japan as reflected in JCOG studies
- (2011) Nobutoshi Ando Esophagus
- Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
- (2010) N C Tebbutt et al. BRITISH JOURNAL OF CANCER
- Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study
- (2010) Yoshihiro Tanaka et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Doxorubicin, cisplatin, and fluorouracil combination therapy for metastatic esophageal squamous cell carcinoma
- (2010) M. Honda et al. DISEASES OF THE ESOPHAGUS
- Treatment Options for Squamous Cell Cancer of the Esophagus: A Systematic Review of the Literature
- (2010) Michael Kranzfelder et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Phase I/II Study of Docetaxel/Cisplatin/Fluorouracil Combination Chemotherapy Against Metastatic Esophageal Squamous Cell Carcinoma
- (2010) Hiroaki Takahashi et al. Journal of Thoracic Oncology
- Advances in esophageal cancer surgery in Japan: An analysis of 1000 consecutive patients treated at a single institute
- (2008) Masaru Morita et al. SURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started